Prenetics Global PRE
NASDAQ PRE
$24.19 +0.00 (+0.00%)
At close: Sep 18, 2026 · 4:00 PM EDT

Prenetics Global (PRE) Net Income towards Common Stockholders (2021 - 2026)

Prenetics Global's (PRE) quarterly Net Income towards Common Stockholders came in at -$8.9 million in Q2 2026, up 26.9% year-over-year from -$7.0 million in Q2 2025, and up 62.07% quarter-over-quarter from -$23.5 million in Q1 2026.

Analysis

Prenetics Global (PRE) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends

Prenetics Global (PRE) has reported Net Income towards Common Stockholders for 6 consecutive years, with -$8.9 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Net Income towards Common Stockholders rose 26.9% year-over-year to -$8.9 million in Q2 2026; TTM through Jun 2026 was -$47.3 million, a 3.83% increase from a year earlier, with the FY2025 full-year figure at $744538.7, up 101.61% from the prior year.
  • Net Income towards Common Stockholders was -$8.9 million for Q2 2026 at Prenetics Global, up from -$23.5 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at -$7.4 million in Q3 2025 and troughed at -$195.3 million in Q4 2022.
  • A 5-year average of -$34.4 million and a median of -$13.1 million in 2023 frame the typical range for Net Income towards Common Stockholders.
  • Across the five-year window, Net Income towards Common Stockholders plunged 1851.36% in 2022 and soared 86.5% in 2023, its largest moves.
  • Over 5 years, Net Income towards Common Stockholders stood at -$195.3 million in 2022, then surged by 67.88% to -$62.7 million in 2023, then jumped by 73.94% to -$16.3 million in 2024, then soared by 54.11% to -$7.5 million in 2025, then dropped by 18.71% to -$8.9 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at -$8.9 million (Q2 2026), -$23.5 million (Q1 2026), and -$7.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 GE HealthCare Technologies 28.97 Bn 27.09 Bn 2.18 Bn 574.00 Mn
2 Lantheus Holdings 6.56 Bn 5.97 Bn 241.86 Mn 75.03 Mn
3 Heartflow 4.40 Bn 4.03 Bn 53.19 Mn -15.74 Mn
4 Neogen 2.83 Bn 2.64 Bn 107.80 Mn -10.50 Mn
5 Butterfly Network 1.88 Bn 1.75 Bn 23.29 Mn -12.91 Mn
6 Ceribell 931.50 Mn 802.24 Mn 25.94 Mn -19.27 Mn
7 Varex Imaging 779.32 Mn 694.02 Mn 76.70 Mn 15.90 Mn
8 Anbio Biotechnology 755.43 Mn 743.53 Mn - -
9 QuidelOrtho 725.35 Mn 601.95 Mn - -
10 Prenetics Global 339.92 Mn 280.78 Mn 30.20 Mn -8.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8.90 Mn
Mar 31, 2026 -23.47 Mn
Dec 31, 2025 -7.50 Mn
Sep 30, 2025 -7.41 Mn
Jun 30, 2025 -12.18 Mn
Mar 31, 2025 -10.39 Mn
Dec 31, 2024 -16.34 Mn
Sep 30, 2024 -10.25 Mn
Jun 30, 2024 -10.92 Mn
Mar 31, 2024 -9.00 Mn
Dec 31, 2023 -62.72 Mn
Sep 30, 2023 -14.00 Mn
Jun 30, 2023 -20.04 Mn
Mar 31, 2023 -10.50 Mn
Dec 31, 2022 -195.30 Mn
Sep 30, 2022 -17.72 Mn
Jun 30, 2022 -148.42 Mn
Mar 31, 2022 -33.52 Mn
Dec 31, 2021 -173.75 Mn
Sep 30, 2021 -80.41 Mn